Safety of Co-Administered CHI-554 and Alcohol

Status:
Not yet recruiting

Trial end date:
2022-07-23

Target enrollment:

Participant gender:

This is a Phase 1, randomized, double-blind study to assess the safety, tolerability, and effects of CHI-554 when co-administered with alcohol.

Phase 1

Canopy Growth Corporation

Auburn University